Yahoo · Oct 28, 2026
OrthoPediatrics: Q3 Earnings Snapshot
(KIDS) on Tuesday reported a loss of $5.The Warsaw, Indiana-based company said it had a loss of 25 cents per share.
KI
NASDAQ · KIDS
OrthoPediatrics Corp.
Healthcare · Medical - Devices
$30.87
Down-$0.65 (-2.06%)
Updated Nov 2, 2026, 6:08 AM
SID Score
6.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 459.56M
- P/E ratio
- -9.41
- Dividend yield
- 0.00%
- 52-week range
- $14.42 – $32.62
- Volume
- 569.93K
- Avg. volume
- 199.33K
Price performance · KIDS
KIDS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
KIDS closed at $30.87 after 20 trading sessions, up 34.86% for the selected period.
- Last close
- $30.87
- Period change
- +34.86%
- Period low
- $21.65
- Period high
- $31.52
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $31.74 | $31.93 | $30.77 | $30.87 | 569.93K |
| Oct 29, 2026 | $30.48 | $32.62 | $30.08 | $31.52 | 834.92K |
| Oct 28, 2026 | $24.94 | $31.51 | $24.79 | $30.80 | 1.79M |
| Oct 27, 2026 | $24.09 | $24.38 | $23.73 | $23.82 | 378.84K |
| Oct 26, 2026 | $24.48 | $24.57 | $23.56 | $24.02 | 378.07K |
| Oct 23, 2026 | $24.43 | $24.70 | $23.75 | $24.50 | 174.63K |
| Oct 22, 2026 | $23.88 | $24.99 | $23.84 | $24.71 | 476.36K |
| Oct 21, 2026 | $23.36 | $23.85 | $23.36 | $23.84 | 490.47K |
| Oct 20, 2026 | $22.27 | $23.54 | $22.27 | $23.50 | 233.3K |
| Oct 19, 2026 | $21.90 | $22.28 | $21.90 | $22.03 | 209.14K |
| Oct 16, 2026 | $22.72 | $22.72 | $21.905 | $21.95 | 149.68K |
| Oct 15, 2026 | $22.30 | $23.13 | $22.30 | $22.57 | 225.7K |
| Oct 14, 2026 | $21.86 | $22.25 | $21.75 | $22.25 | 204.02K |
| Oct 13, 2026 | $22.23 | $22.31 | $21.68 | $21.93 | 196.83K |
| Oct 12, 2026 | $21.60 | $22.305 | $21.60 | $22.08 | 178.43K |
| Oct 9, 2026 | $21.70 | $22.1682 | $21.26 | $21.65 | 135.53K |
| Oct 8, 2026 | $22.34 | $22.34 | $21.63 | $21.76 | 268.33K |
| Oct 7, 2026 | $22.57 | $22.91 | $22.42 | $22.48 | 180.08K |
| Oct 6, 2026 | $23.10 | $23.10 | $22.385 | $22.71 | 237.24K |
| Oct 5, 2026 | $22.04 | $22.93 | $22.04 | $22.89 | 304.77K |
Latest KIDS news
The latest Smart Investors Daily articles mentioning KIDS.
Stock researchCompany · Overview
Company
Market Activity
Research & News
KIDS research
Overview
Company profile and research snapshot.
Company profile
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $24.00
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 28, 2026 | BTIG | Buy | — |
| Oct 28, 2026 | Canaccord Genuity | Buy | — |
| Oct 28, 2026 | Lake Street | Buy | — |
| Oct 28, 2026 | Piper Sandler | Overweight | — |
| Oct 28, 2026 | Stifel | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Oct 28, 2026
BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $30
BTIG analyst Ryan Zimmerman maintains OrthoPediatrics (NASDAQ:KIDS) with a Buy and raises the price target from $29 to $30.
Yahoo · Oct 28, 2026
OrthoPediatrics: 3 Key Takeaways for Long-Term Investors
Disciplined capital spending on surgical sets is finally unlocking positive free cash flow, signaling that the company can scale without burning cash.
Yahoo · Oct 28, 2026
OrthoPediatrics Q3 Earnings Call Highlights
OrthoPediatrics (NASDAQ:KIDS) reported record third-quarter revenue and raised its full-year sales outlook, citing broad-based demand across its trauma, deformity, scoliosis and specialty bracing businesses, as well as continued progress from recently introduced products. Revenue for the third quar
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
